Gemcitabine plus metronoic capecitabine as second/third line chemotherapy in advanced adrenocortical carcinoma. A multicenter phase II trial.

Giuseppe Badalamenti

Gemcitabine plus metronoic capecitabine as second/third line chemotherapy in advanced adrenocortical carcinoma. A multicenter phase II trial.

Discipline Chirurgiche, Oncologiche e Stomatologiche

Risultato della ricerca: Book/Film/Article review

Lingua originale	English
pagine (da-a)	67-
Numero di pagine	1
Rivista	Annals of Oncology
Volume	19
Stato di pubblicazione	Published - 2008

Accesso al documento

OA Link

Cita questo

Badalamenti, G. (2008). Gemcitabine plus metronoic capecitabine as second/third line chemotherapy in advanced adrenocortical carcinoma. A multicenter phase II trial. Annals of Oncology, 19, 67-.

@article{2f60e526b4024950a8256659fcfcc6f4,

title = "Gemcitabine plus metronoic capecitabine as second/third line chemotherapy in advanced adrenocortical carcinoma. A multicenter phase II trial.",

keywords = "adrenocortical carcinoma chemotherapy, adrenocortical carcinoma chemotherapy",

author = "Giuseppe Badalamenti",

year = "2008",

language = "English",

volume = "19",

pages = "67--",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Gemcitabine plus metronoic capecitabine as second/third line chemotherapy in advanced adrenocortical carcinoma. A multicenter phase II trial.

AU - Badalamenti, Giuseppe

PY - 2008

Y1 - 2008

KW - adrenocortical carcinoma chemotherapy

UR - http://hdl.handle.net/10447/44526

M3 - Book/Film/Article review

VL - 19

SP - 67-

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -